# Elite Technology-Transfer Dossier v2 — P-22

**Schema:** ELITE_TECHNOLOGY_TRANSFER_DOSSIER_v2
**R346 upgrades:** {"ownership_made_factual": true, "economic_hypothesis_added": true, "regulatory_firewall_installed": true, "buyer_actions_corrected": true, "independent_qa_performed": true}
**Three axes:** T1 / DECISIVE_EXPERIMENT_REQUIRED / UNCONTACTED

---

## R346 Integrity Upgrades

### Ownership (Gate 1 — factual, not assumed)
- **Ownership status:** UNVERIFIED
- **Reason:** No IP assignment records verified. No patent filings confirmed. CEO must verify ownership before any license/acquisition discussion.
- **Patent status:** NO_PATENT_FILED — we are not running a patent court
- **FTO status:** UNVERIFIED — buyer counsel must perform freedom-to-operate analysis
- **Counsel review:** Full IP diligence by buyer counsel REQUIRED before any commercial engagement

### Economic Hypothesis (Gate 2)
- **Buyer:** Medical device OEM (catheter navigation)
- **Use case:** Autonomous catheter navigation with closed-loop control
- **Economic driver:** Reduction in placement complications and OR time
- **Current solution cost:** $35-50K per revision + OR costs (SOURCE_DERIVED)
- **Potential value driver:** Actuation force sufficient for navigation (MODELLED)
- **Source:** R332 P-22 + model
- **Confidence:** MODELLED — 4 unresolved control problems
- **Unknowns:** ['Buckling safety', 'Closed-loop control in tissue', 'Fault recovery']

### Regulatory Firewall (Gate 3)
- **Facts:** []
- **Hypotheses:** 2 preliminary hypotheses (counsel must confirm)
- **Unknowns:** 6 items
- **Counsel required:** Buyer regulatory counsel REQUIRED to confirm classification, predicate, and testing strategy. Preliminary assessment only — not a regulatory opinion.

### Buyer Action (Gate 6 — fixed)
- **Action:** Commission the decisive experiment ($15-30K (ESTIMATED: SMP prototype + tissue phantom + force sensors)) OR request technical diligence OR request co-development discussion. Licensing is a subsequent 
- **Recommended path:** COMMISSION_EXPERIMENT → CO_DEVELOP / LICENSE IF SUCCESSFUL

### Independent QA (Gate 4)
- **QA passed:** True
- **Claim-evidence links checked:** 3
- **Errors:** NONE
- **Warnings:** NONE
- **Unsupported claims:** NONE
- **Semantic promotions:** NONE
- **Ownership issues:** NONE
- **Regulatory issues:** NONE
- **Economic issues:** NONE
- **Contradictions:** NONE

---

## Buyer Decision Card (v2)

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
BUYER DECISION CARD (v2 — R346 integrity pass)
P-22
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

**TECHNOLOGY**
P-22 — Multi-segment shape-memory polymer catheter with autonomous navigation toward op

**WHY YOU MAY CARE**
A computationally specified P-22 concept plus a preregistered decisive experiment — not a validated technology.

**CURRENT EVIDENCE**
  Technical readiness: T1
  Physical validation: NONE
  Transfer posture: DECISIVE_EXPERIMENT_REQUIRED

**WHAT IS NOT PROVEN**
  - Buckling: catheter WILL buckle before reaching actuation force limit (82x exceedance)
  - Control stability NOT modeled (30s delay makes PID unstable)
  - Tissue safety: effective force 0.039 N exceeds estimated damage threshold 0.01 N by 4x

**STRONGEST ALTERNATIVE**
  Intraoperative placement (surgeon-dependent). Published steerable catheters use closed-loop control + sensing + passive safety (PubMed 25684857).

**DECISIVE QUESTION**
  Can a buckling-safe architecture with closed-loop control navigate safely without tissue damage?

**ECONOMIC HYPOTHESIS**
  Driver: Reduction in placement complications and OR time
  Current cost: $35-50K per revision + OR costs (SOURCE_DERIVED)
  Potential value: Actuation force sufficient for navigation (MODELLED)
  Confidence: MODELLED — 4 unresolved control problems

**REGULATORY STATUS** (preliminary — counsel must confirm)
  HYPOTHESIS: Device classified as Class III — Counsel must confirm.
  HYPOTHESIS: PMA pathway required — Buyer regulatory counsel must confirm. De Novo pathway may be alternatives for some devices.

**OWNERSHIP STATUS**
  UNVERIFIED — No IP assignment records verified. No patent filings confirmed. CEO must verify ownership before any license/acquisition discussion.
  Patent status: NO_PATENT_FILED — we are not running a patent court
  FTO status: UNVERIFIED — buyer counsel must perform freedom-to-operate analysis

**COST TO ANSWER**
  $15-30K (ESTIMATED: SMP prototype + tissue phantom + force sensors)

**TIME**
  8-12 weeks (ESTIMATED: prototype + testing)

**IF PASS**
  Advance to next development phase (see Development Plan)

**IF FAIL**
  Repair / redesign / terminate (see Failure Record)

**WHAT WE ARE ASKING YOU TO DO**
  Commission the decisive experiment ($15-30K (ESTIMATED: SMP prototype + tissue phantom + force sensors)) OR request technical diligence OR request co-development discussion. Licensing is a subsequent route after successful validation.

**BUYER_ACTION_ID**
  P22-EXP-001

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

---

*This is v2 of the elite dossier. R346 applied: factual ownership, economic hypothesis, regulatory firewall, fixed buyer actions, independent QA. See R345 full dossier for Sections 01–15 baseline content.*
